AAM Departures Lead To Change Of Chair For IGBA
Trio Of Executives Leave US Association, Including IGBA Chair For 2023
The AAM has confirmed the departure of three executives, one of whom had also been serving as chair of the IGBA. As a result, the global generics industry association has brought in a new interim chair, at the same time as the head of one of the industry’s largest players has joined its CEO Advisory Committee.
You may also be interested in...
IGBA Seeks To Underline Value And Access
Speaking with Generics Bulletin at the IGBA’s annual conference in February, chair Jonathan Kimball explained how the association is conveying the value of generics and biosimilars to international industry stakeholders.
AAM Names Teva’s Baeder Chair As It Kicks Off Annual Meeting
Christine Baeder has become chair of the AAM’s board, with the Teva executive welcomed to role as the US industry association kicked off its annual Access! conference in Orlando.
Jonathan Kimball Named IGBA Chair For 2023
The IGBA chair passes to Jonathan Kimball. He will head the global off-patent industry organization as it steps up its activities in global policy.